| Advances in pulmonary therapy and drug development: Lung tissue engineering to lung-on-a-chip A Doryab, G Amoabediny, A Salehi-Najafabadi Biotechnology advances 34 (5), 588-596, 2016 | 66 | 2016 |
| Microbiota potential for the treatment of sexual dysfunction H Tirandaz, MB Ebrahim-Habibi, B Moradveisi, S Raoofi, ... Medical Hypotheses 115, 46-49, 2018 | 14 | 2018 |
| The effects of sesquiterpene lactones on the differentiation of human or animal cells cultured in-vitro: A critical systematic review S Tehrani Fateh, S Tehrani Fateh, F Shekari, M Mahdavi, AR Aref, ... Frontiers in Pharmacology 13, 1023, 2022 | 7* | 2022 |
| Growth kinetics and ganoderic acid production from Ganoderma lucidum GIRAN17: A real-time monitoring platform M Heydarian, A Hatamian-Zarmi, G Amoabediny, ... Iranian Journal of Medical Microbiology 15 (1), 67-84, 2021 | 7 | 2021 |
| Biotransformation of trinitrotoluene (TNT) by newly isolated slight halophilic bacteria M Ali-Begloui, E Salehghamari, S Sadrai, M Ebrahimi, MA Amoozegar, ... Microbiology 89, 616-625, 2020 | 6 | 2020 |
| Biotransformation of isobutyraldehyde to isobutanol by an engineered Escherichia coli strain M Hosseini, M Ebrahimi, E Salehghamari, A Salehi Najafabadi, ... Journal of Applied Biotechnology Reports 7 (3), 159-165, 2020 | 3 | 2020 |
| Protein corona: challenges and opportunities for cancer therapy ST Fateh, F Mehryab, ST Fateh, A Salehi-Najafabadi, AR Aref Functionalized Nanomaterials for Cancer Research, 683-697, 2024 | 1 | 2024 |
| An overview of the recent findings of cell-based therapies for the treatment and management of COVID-19 S Ghaffari, H Kazerooni, A Salehi-Najafabadi International Immunopharmacology 101, 108226, 2021 | 1 | 2021 |
| Cytosine deaminase producing Clostridium may be used in detection of tumors. H Tirandaz, A Salehi-Najafabadi, A Eslamifar Medical hypotheses 67 (5), 1257-1258, 2006 | 1 | 2006 |
| Bioactive compounds of the Actinomycetes isolated from Garmsar Saline River, Iran E Salehghamari, M Sardabi, F Bahrami, EF Mobarakeh, A Seddighi, ... | | 2024 |
| Insights into additional lactone-based signaling circuits in Streptomyces: existence of acyl-homoserine lactones and LuxI/LuxR homologs in six Streptomyces species A Salehi-Najafabadi, S Tehrani Fateh, G Amoabediny, J Hamedi Frontiers in Microbiology 15, 1342637, 2024 | | 2024 |
| Nanomaterials affecting cellular metabolism: opportunities and challenges for cancer therapy ST Fateh, ST Fateh, A Salehi-Najafabadi, AR Aref Functionalized Nanomaterials for Cancer Research, 699-717, 2024 | | 2024 |
| Commercial and regulatory challenges in cancer nanomedicine ST Fateh, ST Fateh, A Salehi-Najafabadi, AR Aref Functionalized Nanomaterials for Cancer Research, 579-601, 2024 | | 2024 |
| Gamma Butyrolactone Derivatives for Inducing Differentiation in Neoplastic Cells ST Fateh, ST Fateh, A Salehi-Najafabadi US Patent App. 18/336,744, 2023 | | 2023 |
| Healthy Male Individuals Possess Higher Plasma HER-2 Level than Females ST Fateh, A Behgozin, F Yekani, L Geranpayeh, A Olfatbakhsh, ... Cell Journal (Yakhteh) 25 (1), 73, 2023 | | 2023 |
| Repurposing of substances with lactone moiety for the treatment of γ-Hydroxybutyric acid and γ-Butyrolactone intoxication through modulating paraoxonase and PPARγ S Tehrani Fateh, A Salehi-Najafabadi Frontiers in Pharmacology, 2022 | | 2022 |
| The Immunomodulatory Effects of Probiotics on Respiratory Viral Infections: A Hint for COVID-19 Prophylaxis? H Ahanchian, R Tafrishi Immunology and Genetics Journal, 2022 | | 2022 |
| The current advances of CRISPR/Cas-based systems for the detection of COVID-19 S Ghaffari, H Kazerooni, A Salehi-Najafabadi Journal of Current Biomedical Reports 2 (4), 159-167, 2021 | | 2021 |
| A single-center retrospective cohort study of Covid-19 medications: Remdesivir, Favipiravir, Methylprednisolone, Dexamethasone, and Interferon β1a and their combinations ST Fateh, ST Fateh, E Salehi, N Rezai, N Haririan, A Asgari, ... medRxiv, 2021.03. 05.21251351, 2021 | | 2021 |
| An overview of the recent findings of cell-based therapies for the treatment and management of COVID-19 ASN Sasan Ghaffari, Hanif Kazerooni International Immunopharmacology 101, 2021 | | 2021 |
Ghassem Amoabediny,Professor of Biomedical /Nanobiotechnology, University of Tehran and VUmc Amsterdam在 ut.ac.ir 的电子邮件经过验证
